Iovance builds gene therapy manufacturing facility in Philadelphia 30-May-2019 By Maggie Lynch Iovance amps up clinical and commercial immunotherapy production with a $75m (€67.3m), 136,000 square-foot build in Philadelphia’s Navy Yard.
Thermo Fisher acquires gene therapy CDMO Brammer Bio 25-Mar-2019 By Maggie Lynch Thermo Fisher Scientific bolsters its gene therapy capabilities by acquiring Brammer Bio for $1.7bn, as the market becomes an ‘increasing focus’ for customers.
German biotech opens US office to expand its global presence 05-Feb-2019 By Maggie Lynch Sirion Biotech has opened a US-based office to support local gene therapy research and clinical development with viral vector contract manufacturing.
Selecta hires Lonza to make synthetic vector delivered gene therapy 17-Feb-2017 By Gareth Macdonald Selecta Biosciences Inc. has hired Swiss contractor Lonza to make a gene therapy candidate for the metabolic disease, Methylmalonic Acidemia (MMA).
